CJC-1295 Without DAC (5 mg)

CJC-1295 Without DAC, also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH) developed for scientific research involving growth hormone signaling and endocrine regulation. Unlike the DAC version, this peptide does not contain the Drug Affinity Complex (DAC), resulting in a shorter duration of activity that makes it particularly useful for studying pulsatile growth hormone release and receptor signaling.

Each vial contains 5 mg of research-grade CJC-1295 Without DAC, supplied as a lyophilized powder to preserve stability and purity during storage. Manufactured according to rigorous research standards, this peptide is intended exclusively for laboratory and in-vitro research conducted by qualified professionals.

For laboratory research use only. Not intended for human or veterinary consumption.

What Is CJC-1295 Without DAC?

CJC-1295 Without DAC is a modified version of growth hormone-releasing hormone consisting of the active GRF (1-29) sequence with structural modifications that improve peptide stability. Because it lacks the Drug Affinity Complex (DAC), it exhibits a significantly shorter half-life than CJC-1295 DAC, allowing researchers to investigate growth hormone signaling over shorter time periods.

Researchers continue to study this peptide for its interaction with GHRH receptors and its influence on endocrine signaling, hormone regulation, and cellular communication.

Its predictable activity profile has made CJC-1295 Without DAC an important research tool in peptide and hormone biology.

Areas of Scientific Research

CJC-1295 Without DAC has been investigated in laboratory and preclinical studies across several areas of endocrine and peptide research. Current investigations include:

• Growth hormone signaling
• Growth hormone-releasing hormone (GHRH) receptor research
• Endocrine system biology
• Hormone secretion pathways
• Cellular signaling mechanisms
• Metabolic regulation research
• Peptide-receptor interactions
• Neuroendocrine physiology

Although research continues to expand scientific understanding, CJC-1295 Without DAC remains a research peptide intended exclusively for laboratory investigation.

Mechanism of Action

Researchers study CJC-1295 Without DAC for its ability to bind to growth hormone-releasing hormone receptors and activate signaling pathways associated with endogenous growth hormone release. Because it lacks the Drug Affinity Complex, it is commonly used to investigate short-duration receptor activation and pulsatile hormone signaling.

Current laboratory research examines its role in:

• GHRH receptor activation
• Growth hormone signaling pathways
• Endocrine communication
• Peptide-mediated cellular signaling
• Hormonal regulation mechanisms
• Metabolic signaling research

These investigations continue to improve scientific understanding of endocrine physiology and peptide biology.

CJC-1295 Without DAC vs CJC-1295 DAC

Researchers frequently compare CJC-1295 Without DAC vs CJC-1295 DAC because both peptides are based on Modified GRF (1-29) but differ in their duration of activity.

CJC-1295 Without DAC has a shorter half-life and is commonly studied for pulsatile growth hormone signaling and short-term receptor activation. CJC-1295 DAC contains a Drug Affinity Complex that extends its biological activity, making it suitable for research involving prolonged growth hormone stimulation.

These comparisons help researchers better understand receptor kinetics, hormone regulation, and peptide pharmacology.

Product Specifications

Specification	Details
Product Name	CJC-1295 Without DAC (Modified GRF 1-29)
Strength	5 mg
Peptide Type	Synthetic GHRH Analog
Form	Lyophilized Powder
Primary Research Area	Growth Hormone Signaling
Purity	Research Grade
Intended Use	Laboratory Research Only
Storage	Cool, dry place

 

Quality Standards

Our CJC-1295 Without DAC peptide is manufactured to support professional laboratory research where purity, consistency, and reliability are essential. Every production batch undergoes carefully controlled manufacturing and quality assurance procedures to provide dependable peptide material for scientific investigations.

Key quality features include:

• Research-grade peptide material
• High-purity manufacturing standards
• Stable lyophilized powder formulation
• Secure packaging for product protection
• Suitable for laboratory and analytical research

Researchers can rely on consistent product quality for controlled experimental studies involving peptide and endocrine biology.

Storage Instructions

Proper storage helps preserve peptide stability and integrity throughout laboratory research.

For optimal handling:

• Store unopened vials in a cool, dry location.
• Protect from excessive heat, moisture, and direct sunlight.
• After reconstitution, follow your laboratory’s established storage procedures.
• Avoid repeated freeze-thaw cycles whenever possible.

Always handle research compounds using appropriate laboratory equipment and laboratory safety protocols.

Why Researchers Choose CJC-1295 Without DAC

CJC-1295 Without DAC is widely studied for its short-duration activity and its role in growth hormone-releasing hormone research. Its modified structure makes it a valuable peptide for laboratory investigations involving endocrine signaling.

Researchers choose CJC-1295 Without DAC because it offers:

• A modified GRF (1-29) peptide for GHRH receptor research.
• Applications in growth hormone signaling and endocrine studies.
• A shorter activity profile for investigating pulsatile hormone release.
• High-purity lyophilized formulation for reliable laboratory handling.
• Research-grade quality standards suitable for universities, biotechnology companies, and research laboratories.

Its well-established scientific profile continues to support investigations into hormone biology, peptide signaling, and endocrine regulation.

Frequently Asked Questions

What is CJC-1295 Without DAC used for in research?

CJC-1295 Without DAC is commonly studied in laboratory research involving growth hormone signaling, GHRH receptor activity, endocrine regulation, and peptide-mediated cellular communication.

What form does this product come in?

Each vial contains 5 mg of lyophilized CJC-1295 Without DAC peptide powder intended exclusively for laboratory and in-vitro research.

What is the difference between CJC-1295 Without DAC and CJC-1295 DAC?

CJC-1295 Without DAC has a shorter duration of activity because it does not contain the Drug Affinity Complex (DAC). CJC-1295 DAC is designed for extended activity, making each peptide suitable for different laboratory research objectives.

How should CJC-1295 Without DAC be stored?

Store the unopened vial in a cool, dry place away from heat, moisture, and direct sunlight. After reconstitution, follow your laboratory’s recommended storage procedures.

Is this product intended for human use?

No. This product is supplied exclusively for laboratory research purposes and is not intended for human or veterinary consumption.

Research Use Disclaimer

This product is supplied exclusively for laboratory research, analytical testing, and scientific investigation. It is not intended for human consumption, veterinary use, therapeutic applications, or diagnostic procedures. By purchasing this product, researchers acknowledge responsibility for handling and using the compound in accordance with applicable laboratory regulations and safety guidelines.